la

ACS launches virtual platform for sharing research from Philadelphia national meeting




la

Mitsubishi dusts off plan to build US methyl methacrylate plant




la

Texas polyester plant is on hold




la

BASF subsidiary trinamiX launches handheld near-infrared spectrometer




la

Design Therapeutics launches with $45 million for neurological diseases




la

Wanted: Data to make labs safer

Researchers aim to supply evidence to save lives, persevering through lack of recognition and funding




la

Video: Chemistry turns backyard clay into a 3-D printable building material

Technology could lessen the environmental impact of 3-D printed buildings by adapting locally harvested soils




la

Chemistry in Pictures: Giant glassware




la

Asbestos inhalation poses cancer risks to workers and consumers

US EPA finds unreasonable risks for 6 current uses, including chlor-alkali diaphragms




la

Ceramic lattices that are stronger than diamond

New design based on interconnected plates pushes theoretical strength limits




la

Laser burns graphene onto Kevlar to power up protective gear

Using lasers to directly create graphene on Kevlar makes it easy to integrate electronics on textiles




la

COVID-19 to delay clinical trials

Drugmakers want to keep trials going but acknowledge that medical resources are strained




la

Is a reagents shortage delaying European COVID-19 testing?

Fingers are being pointed in the Netherlands and the UK over reagent capacity constraints




la

Zymergen, Sumitomo launch biobased film for electronics




la

Sanofi and Translate Bio add coronavirus to vaccine pact




la

Arkema plans to exit intermediate chemical businesses




la

Video: Chemistry turns backyard clay into a 3-D printable building material

Technology could reduce the environmental impact of 3-D printed buildings by adapting locally harvested soils




la

Chemistry in Pictures: Milky Way malady




la

Plastic bag bans rolled back for COVID-19

Regulators are restricting reusable bags over worries they might harbor virus




la

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease




la

Plastic bag bans rolled back for COVID-19

Regulators are restricting reusable bags over worries they might harbor virus




la

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease




la

Rgenta Therapeutics launches with $20 million to develop small molecules that target RNA




la

Graphene and black phosphorus get tough

Two 2-D materials team up to create a composite with record toughness




la

Plasmonic color offers durability, ultra-high resolution, and low cost

The phenomenon behind the earliest photographs is making a comeback, inspiring new research in color printing and displays




la

Pentachlorophenol is on its way out as a utility pole preservative. Here's what might take its place

Phaseout is pushing a slow-to-change industry to look at alternatives




la

What explains the non-respiratory symptoms seen in some COVID-19 patients?

Some patients experience neurological, cardiovascular, and intestinal symptoms after infection with SARS-CoV-2




la

US EPA won't strengthen particulate matter limit

Chemical industry backs plan to keep current standard




la

Blackstone invests in Alnylam's RNAi therapies




la

MOMA Therapeutics launches with $86 million series A to drug molecular machines




la

How one ACS division took its Philadelphia technical program virtual

Members of the Division of Colloid and Surface Chemistry presented 155 virtual talks over 3 days




la

i2O launches for ionic liquid–based drug delivery




la

North Carolina rejects Chemours's PFAS cleanup plan




la

Environmental toxicologist wants to understand how microplastics affect human health

Stephanie Wright of King's College London discusses what's known about microplastics and how much more there is to learn




la

Mercury move portends similar deregulation of air pollution by US EPA

Planned changes could mean weaker emission controls for chemical industry




la

COVID-19 claims the life of beloved chemistry professor

Dennis Peters of Indiana University dies from complications of COVID-19




la

Clinical trials planned to put hydroxychloroquine to the test for COVID-19

The antimalaria drug will be tested for treating or preventing the disease in thousands of people worldwide




la

BASF collaborates on chemical bar code




la

Astellas acquires Nanna Therapeutics




la

Ineos to squeeze oil from waste plastic




la

Mercury move portends similar deregulation of air pollution by US EPA

Planned changes could mean weaker emission controls for chemical industry




la

Will EPA ban hazardous pesticide in pet collars?

Federal appeals court orders agency to make a decision within 90 days




la

Ultrabright fluorescent label improves assay speed and sensitivity

Combining gold nanorod with multiple fluorophores boosts bioassay performance




la

Sweet-smelling study aids, and why stinky plastic is a trap for turtles




la

Rome Therapeutics launches to probe junk DNA for cancer drug discovery

Biotech veteran Rosana Kapeller co-founded the start-up, which raised $50 million to develop small-molecule drugs




la

Career Ladder: Abril Estrada

This biomaterials chemist makes pet food proteins from nonanimal sources




la

Finding what cells the coronavirus can enter could help explain why it spreads so well

Two studies pinpoint nasal cells and others that express the molecules the virus uses to get inside




la

US national labs offer royalty-free patent licenses

The nonexclusive licenses, available on more than 1,000 technologies, will expire at the end of 2020




la

Will EPA ban hazardous pesticide in pet collars?

Federal appeals court orders agency to make a decision within 90 days




la

Rome Therapeutics launches to probe junk DNA for cancer drug discovery

Biotech veteran Rosana Kapeller cofounded the start-up, which raised $50 million to develop small-molecule drugs